Long-term adefovir dipivoxil treatment induces regression of liver fibrosis in patients with HBeAg-negative chronic hepatitis B: Results after 5 years of therapy

被引：0
|
作者：
Hadziyannis, S
Tassopoulos, N
Chang, TT
Heathcote, J
Kitis, G
Rizzetto, M
Marcellin, P
Lim, SG
Goodman, Z
Arterburn, S
Ma, J
Xiong, S
Borroto-Esoda, K
Brosgart, C
Currie, G
机构：
[1] Henry Dunant Hosp, Athens 70101, Greece
[2] Western Attica Gen Hosp, Athens, M5T 2S8, Greece
[3] Natl Cheng Kung Univ, Tainan, Taiwan
[4] Toronto Western Hosp, Toronto, ON, Canada
[5] Georgios Papanikolaou Dist Hosp, Thessaloniki, Greece
[6] Azienda Osped San Giovanni Battista, Turin 117548, Italy
[7] Hop Beaujon, Clichy, 20306, France
[8] Natl Univ Singapore Hosp, Singapore, 94404, Singapore
[9] Armed Forces Inst Pathol, Washington, DC USA
[10] Gilead Sci Inc, Foster City, CA USA
[11] Gilead Sci Inc, Durham, NC USA
来源：
HEPATOLOGY | 2005年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：754A / 754A
页数：1
相关论文
共 50 条
  • [1] Long-term adefovir dipivoxil treatment induces regression of liver fibrosis in patients with HBeAg-negative chronic hepatitis B: results after 5 years of therapy
    Hadziyannis, Stephanos
    Tassopoulos, Nicolaos
    Chang, Ting-Tsung
    Heathcote, E. Jenny
    Kitis, George
    Rizzetto, Mario
    Marcellin, Patrick
    Lim, Seng Gee
    Goodman, Zachary
    Arterburn, Sarah
    Ma, Jia
    Borroto-Esoda, Katyna
    Mondou, Elsa
    Chuck, Steven
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A23 - A24
  • [2] Long-term adefovir dipivoxil treatment induces regression of liver fibrosis in patients with HBeAg-negative chronic hepatitis B: results after 5 years of therapy
    Hadziyannis, S. J.
    Tassopoulos, N. C.
    Chang, T.
    Heathcote, J.
    Kitis, G.
    Rizzetto, M.
    Marcellin, P.
    Lim, S.
    Goodman, Z.
    Arterburn, S.
    Ma, J.
    Borroto-Esoda, K.
    Mondou, E.
    Chuck, S. L.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S92 - S92
  • [3] Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
    Hadziyannis, Stephanos J.
    Tassopoulos, Nicolaos C.
    Heathcote, E. Jenny
    Chang, Ting-Tsung
    Kitis, George
    Rizzetto, Mario
    Marcellin, Patrick
    Lik, Seng Gee
    Goodman, Zachary
    Ma, Jia
    Brosgart, Carol L.
    Eorroto-Esoda, Katyna
    Arterburn, Sarah
    Chuck, Steven L.
    [J]. GASTROENTEROLOGY, 2006, 131 (06) : 1743 - 1751
  • [4] Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
    Hadziyannis, SJ
    Tassopoulos, NC
    Heathcote, EJ
    Chang, TT
    Kitis, G
    Rizzetto, M
    Marcellin, P
    Lim, SG
    Goodman, Z
    Ma, J
    Arterburn, S
    Xiong, S
    Currie, G
    Brosgart, CL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26): : 2673 - 2681
  • [5] Long term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
    Bhushan, B.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S95 - S95
  • [6] OUTCOME OF HBeAg-NEGATIVE CHRONIC HEPATITIS B (CHB) 5 YEARS AFTER DISCONTINUATION OF LONG TERM ADEFOVIR DIPIVOXIL (ADV) TREATMENT
    Hadziyannis, S.
    Sevastianos, V.
    Rapti, I.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S9 - S10
  • [7] EFFECTIVENESS OF LONG-TERM COMBINATION THERAPY WITH ADEFOVIR DIPIVOXIL AND LAMIVUDINE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B AND LAMIVUDINE RESISTANCE
    Manolakopoulos, Spilios
    Striki, Athanasia
    Papatheodoridis, George V.
    Deutsch, Melanie
    Mela, Maria
    Tzourmakliotis, Dimitrios
    Manesis, Emanuel K.
    Archimandritis, Athanasios J.
    [J]. HEPATOLOGY, 2009, 50 (04) : 520A - 521A
  • [8] Long-term therapy with adefovir dipivoxil for HBeAg positive chronic hepatitis B: results from 144 weeks adefovir dipivoxil treatment
    You, J.
    Zhuang, L.
    Chen, H. Y.
    Feng, X.
    Kong, L.
    Lei, H.
    Ma, Y. L.
    Li, Y. L.
    Yang, W. B.
    Huang, J. H.
    Yan, S. M.
    Che, Y. H.
    Wang, Q. Q.
    Chen, L.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S30 - S30
  • [9] Long-term treatment with adefovir dipivoxil is more cost-effective than lamivudine for HBeAg-negative patients with chronic hepatitis B
    Buti, M
    Casado, MA
    Calleja, JL
    Salmerón, J
    Aguilar, J
    Rueda, M
    Esteban, R
    [J]. HEPATOLOGY, 2005, 42 (04) : 354A - 354A
  • [10] Long-term therapy with adefovir dipivoxil for HBeAg positive chronic hepatitis B patients with various baseline biochemical levels: Results from 4 years adefovir dipivoxil treatment
    Zhuang, L.
    You, J.
    Kong, L.
    Li, Y. L.
    Lei, H.
    Ma, Y. L.
    Chen, H. Y.
    Liu, H. E.
    Feng, X.
    Ma, S. J.
    Huang, J. H.
    Che, Y. H.
    Wang, Q. Q.
    Chen, L.
    Yan, S. M.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 319 - 319
12345